Adicet Bio, Inc. Common Stock (ACET) is a publicly traded Healthcare sector company. As of November 5, 2026, ACET trades at $2.94 with a market cap of $29.02M and a P/E ratio of -0.38. ACET moved -5.65% today. Year to date, ACET is -64.02%; over the trailing twelve months it is -73.44%. Its 52-week range spans $2.89 to $17.44. Analyst consensus is strong buy with an average price target of $25.00. Rallies surfaces ACET's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ACET combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.94 |
| Market Cap | $29.02M |
| P/E Ratio | -0.38 |
| EPS | $-16.95 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.44 |
| 52-Week Low | $2.89 |
| Volume | 407.59K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-116.80M |
| Gross Margin | 0.00% |
4 analysts cover ACET: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $25.00.